Iridius | $8,600,000 | (Apr 28, 2026)
Audion | $15,000,000 | (Apr 28, 2026)
Decade Energy | $25,763,540 | (Apr 28, 2026)
Life Biosciences
United States
- Boston, Massachusetts
- 09/04/2026
- Series D
- $80,000,000
Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical
unmet needs.
- Industry Biotechnology
- Website https://www.lifebiosciences.com/
- LinkedIn https://www.linkedin.com/company/lifebiosciences/
Related People
Jerry McLaughlinFounder
United States -
Washington Crossing, Pennsylvania
Independent board director and biotech CEO with a record of leading clinical- and commercial-stage companies through strategic growth, financing, and successful exits. I bring over 35 years of experience across biotech and pharma, spanning corporate development, commercialization, M&A, IPO execution, and corporate governance.
Over the course of my career, I have raised more than $0.5 billion in equity and debt across public and private markets, built and restructured organizations, and guided companies through pivotal value-inflection points. I thrive at the intersection of science, strategy, and capital, helping boards and management teams align pipeline advancement with sustainable growth and exit readiness.
I am motivated by the opportunity to translate breakthrough science into patient impact and shareholder value, and I bring a steady, disciplined perspective to governance and strategic decision-making.
TriFetch | $1,900,000 | (Apr 28, 2026)
Fathom Therapeutics | $47,000,000 | (Apr 28, 2026)
SquareMind | $18,000,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)
Cnuic Technologies | $3,000,000 | (Apr 28, 2026)
Zócalo Health | $15,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)